Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizumab) in renal transplant recipients - Concepedia

Concepedia

Publication | Closed Access

Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizumab) in renal transplant recipients

35

Citations

14

References

2001

Year

M.P. Nair, M.R.N. Nampoory, K.V. Johny, J.N Costandi, Medhat Abdulhalim, Wael El-Reshaid, I. Al-Muzairai, V.T. Ninan, M Samhan, M Al-Mousawi

Transplantation Proceedings

Transplant RejectionUrologyTransplantationAutoimmune DiseaseKidney TransplantMedicineKidney TransplantationImmunosuppressive TherapyImmunologyAutoimmunityRenal Transplant RecipientsInduction ImmunosuppressionImmunotherapyTransplant ImmunologyNephrologyGraft RejectionInterleukin-2 Receptor Antibodies

References

	Year	Citations

Page 1

Page 1